Literature DB >> 23223064

Hiding under the skin: A welcome surprise in psoriasis.

James G Krueger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23223064     DOI： 10.1038/nm.3025

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.

Authors:  Astrid B Van Belle; Magali de Heusch; Muriel M Lemaire; Emilie Hendrickx; Guy Warnier; Kyri Dunussi-Joannopoulos; Lynette A Fouser; Jean-Christophe Renauld; Laure Dumoutier
Journal:  J Immunol       Date:  2011-11-30       Impact factor: 5.422

2.  Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.

Authors:  Yan Zheng; Dimitry M Danilenko; Patricia Valdez; Ian Kasman; Jeffrey Eastham-Anderson; Jianfeng Wu; Wenjun Ouyang
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

Review 3.  Psoriasis: comorbidities and associations.

Authors:  E Farley; A Menter
Journal:  G Ital Dermatol Venereol       Date:  2011-02       Impact factor: 2.011

4.  Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis.

Authors:  Craig Leonardi; Robert Matheson; Claus Zachariae; Gregory Cameron; Linda Li; Emily Edson-Heredia; Daniel Braun; Subhashis Banerjee
Journal:  N Engl J Med       Date:  2012-03-29       Impact factor: 91.245

5.  Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.

Authors:  Kim A Papp; Craig Leonardi; Alan Menter; Jean-Paul Ortonne; James G Krueger; Gregory Kricorian; Girish Aras; Juan Li; Chris B Russell; Elizabeth H Z Thompson; Scott Baumgartner
Journal:  N Engl J Med       Date:  2012-03-29       Impact factor: 91.245

Review 6.  Interleukin-17 contributes to cardiovascular diseases.

Authors:  Hua-Sheng Ding; Jun Yang; Jian Yang; Jia-Wang Ding; Ping Chen; Ping Zhu
Journal:  Mol Biol Rep       Date:  2012-02-14       Impact factor: 2.316

7.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

8.  IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis.

Authors:  James G Krueger; Scott Fretzin; Mayte Suárez-Fariñas; Patrick A Haslett; Krista M Phipps; Gregory S Cameron; Juliet McColm; Artemis Katcherian; Inna Cueto; Traci White; Subhashis Banerjee; Robert W Hoffman
Journal:  J Allergy Clin Immunol       Date:  2012-06-05       Impact factor: 10.793

Review 9.  Putting together the psoriasis puzzle: an update on developing targeted therapies.

Authors:  Leanne M Johnson-Huang; Michelle A Lowes; James G Krueger
Journal:  Dis Model Mech       Date:  2012-07       Impact factor: 5.758

10.  Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis.

Authors:  Mayte Suárez-Fariñas; Katherine Li; Judilyn Fuentes-Duculan; Karen Hayden; Carrie Brodmerkel; James G Krueger
Journal:  J Invest Dermatol       Date:  2012-07-05       Impact factor: 8.551
View more
  18 in total

1.  miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis.

Authors:  Helen Hermann; Toomas Runnel; Alar Aab; Hansjörg Baurecht; Elke Rodriguez; Nathaniel Magilnick; Egon Urgard; Liisi Šahmatova; Ele Prans; Julia Maslovskaja; Kristi Abram; Maire Karelson; Bret Kaldvee; Paula Reemann; Uku Haljasorg; Beate Rückert; Paulina Wawrzyniak; Michael Weichenthal; Ulrich Mrowietz; Andre Franke; Christian Gieger; Jonathan Barker; Richard Trembath; Lam C Tsoi; James T Elder; Eric R Tkaczyk; Kai Kisand; Pärt Peterson; Külli Kingo; Mark Boldin; Stephan Weidinger; Cezmi A Akdis; Ana Rebane
Journal:  J Invest Dermatol       Date:  2017-06-06       Impact factor: 8.551

2.  Ozonated autohemotherapy elevates PPAR-γ expression in CD4+ T cells and serum HDL-C levels, a potential immunomodulatory mechanism for treatment of psoriasis.

Authors:  Jinrong Zeng; Zhen Tang; Yuezhong Zhang; Xiaoliang Tong; Jianhua Dou; Lihua Gao; Shu Ding; Jianyun Lu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

Review 3.  Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies.

Authors:  Judy H Cho; Marc Feldman
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

4.  In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORγt and IL-17.

Authors:  Romy R M C Keijsers; Anke G M Hendriks; Piet E J van Erp; Bram van Cranenbroek; Peter C M van de Kerkhof; Hans J P M Koenen; Irma Joosten
Journal:  J Invest Dermatol       Date:  2013-12-06       Impact factor: 8.551

5.  MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation.

Authors:  Ruifang Wu; Jinrong Zeng; Jin Yuan; Xinjie Deng; Yi Huang; Lina Chen; Peng Zhang; Huan Feng; Zixin Liu; Zijun Wang; Xiaofei Gao; Haijing Wu; Honglin Wang; Yuwen Su; Ming Zhao; Qianjin Lu
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

6.  GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis.

Authors:  Xichun Xia; Guangchao Cao; Guodong Sun; Leqing Zhu; Yixia Tian; Yueqi Song; Chengbin Guo; Xiao Wang; Jingxiang Zhong; Wei Zhou; Peng Li; Hua Zhang; Jianlei Hao; Zhizhong Li; Liehua Deng; Zhinan Yin; Yunfei Gao
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

7.  Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors.

Authors:  R C Li; P Krishnamoorthy; S DerOhannessian; J Doveikis; M Wilcox; P Thomas; D J Rader; M P Reilly; A Van Voorhees; J M Gelfand; N N Mehta
Journal:  Clin Exp Dermatol       Date:  2014-01       Impact factor: 3.470

Review 8.  The microbiome and psoriatic arthritis.

Authors:  Hester Eppinga; Sergey R Konstantinov; Maikel P Peppelenbosch; H Bing Thio
Journal:  Curr Rheumatol Rep       Date:  2014-03       Impact factor: 4.592

Review 9.  Targeting interleukin-22 in psoriasis.

Authors:  Ji-Qing Hao
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

10.  Tumour necrosis factor alpha, interferon gamma and substance P are novel modulators of extrapituitary prolactin expression in human skin.

Authors:  Ewan A Langan; Silvia Vidali; Natascha Pigat; Wolfgang Funk; Erika Lisztes; Tamás Bíró; Vincent Goffin; Christopher E M Griffiths; Ralf Paus
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.